Breast cancer
Results
Other
This trial was done to find out more about levels of ctDNA after treatment for . It also looked at whether pembrolizumab is a useful treatment for people who have ctDNA.
The trial was open for people to join between December 2017 and December 2019. The team published the results in 2023.
Recruitment start: 21 December 2017
Recruitment end: 6 December 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nicholas Turner
Cancer Research UK
Le Cure
Merck, Sharp & Dohme
NIHR Royal Marsden Biomedical Research Centre
The Institute of Cancer Research (ICR)
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUKE/16/024
Last reviewed: 05 Oct 2023
CRUK internal database number: 14957
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
